X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
PLETHICO PHARMA Quarterly Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA Quarterly Results   (PLPL)

Here are the latest quarterly results of PLETHICO PHARMA. For more details, see the PLETHICO PHARMA financial fact sheet and PLETHICO PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

PLETHICO PHARMA Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-13
*
3
Jun-13
*
3
Sep-13
*
3
Dec-13
*
3
Mar-14
*
3
Jun-14
*
3
Sep-14
*
3
Dec-14
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m4,9055,1824,7073,6443,1022,7792,6301,114 
Other income Rs m112200-441 
Turnover Rs m4,9065,1944,7093,6433,1022,7752,6341,116 
Expenses Rs m4,5864,0063,9252,6472,6172,2722,113931 
Gross profit Rs m3191,176782997485506516183 
Depreciation Rs m3710172274158152154108 
Interest Rs m154353227289570363520117 
Profit before tax Rs m129734486433-243-12-153-41 
Tax Rs m25-6835-8-1234-900 
Profit after tax Rs m104802451441-120-17-63-41 
Gross profit margin %6.522.716.627.415.618.219.616.5 
Effective tax rate %19.4-9.37.2-1.750.7-34.558.90.0 
Net profit margin %2.115.59.612.1-3.9-0.6-2.4-3.6 
Diluted EPS Rs 3.1 23.5 13.2 12.9 -3.5 -0.5 -1.9 -1.2  
Diluted EPS (TTM) Rs 36.6 31.6 31.1 52.8 46.2 22.2 7.1 -7.1  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   NATCO PHARMA  IPCA LABS  DR. REDDYS LAB  PIRAMAL ENTERPRISES  INDRAPRASTHA MEDICAL  

Compare PLETHICO PHARMA With:   NATCO PHARMA  IPCA LABS  DR. REDDYS LAB  PIRAMAL ENTERPRISES  INDRAPRASTHA MEDICAL  

Compare PLETHICO PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Nifty Ends Flat After Hitting 10,000 Mark; Where Should You Invest Now?(Closing)

Share markets in India ended the day on a flat note after the Nifty 50 hit the crucial 10,000 mark for the first time ever. At the closing bell, the BSE Sensex closed lower by 18 points.

Views on news

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

More Views on News

Most Popular

Ride the Bull Wave with These Perfect Proxies to India's Growth Story(The 5 Minute Wrapup)

Jul 15, 2017

The secret of spotting multibaggers before they become a hit.

The Real Returns from Real Estate Have Been Very Low(Vivek Kaul's Diary)

Jul 17, 2017

Real estate prices across India have barely gone anywhere over the last four years. Prices have fallen in many cities over the last one-year, new data from the National Housing Bank suggests.

The New Pharma Rally Starts NOW(Daily Profit Hunter)

Jul 12, 2017

The most hated sector is offering the best trading opportunity. Are you ready?

All You Need To Know To e-File Your Income Tax Returns(Outside View)

Jul 12, 2017

The Income Tax return filing deadline is drawing near; if you have not already filed your taxes, here's how to do it.

Sold Your Immoveable Property? Here Are The Tax Implications...(Outside View)

Jul 19, 2017

When you're selling an immoveable property, it becomes imperative to recognise the intricate tax implications.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA - TORRENT PHARMA COMPARISON

COMPARE PLETHICO PHARMA WITH

MARKET STATS